Relay Therapeutics (RLAY) Profit After Tax (2020 - 2025)
Historic Profit After Tax for Relay Therapeutics (RLAY) over the last 6 years, with Q3 2025 value amounting to -$74.1 million.
- Relay Therapeutics' Profit After Tax rose 1584.02% to -$74.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$297.6 million, marking a year-over-year increase of 1379.09%. This contributed to the annual value of -$337.7 million for FY2024, which is 124.72% up from last year.
- Latest data reveals that Relay Therapeutics reported Profit After Tax of -$74.1 million as of Q3 2025, which was up 1584.02% from -$70.4 million recorded in Q2 2025.
- In the past 5 years, Relay Therapeutics' Profit After Tax registered a high of -$42.2 million during Q1 2021, and its lowest value of -$193.4 million during Q2 2021.
- In the last 5 years, Relay Therapeutics' Profit After Tax had a median value of -$76.8 million in 2022 and averaged -$81.9 million.
- Per our database at Business Quant, Relay Therapeutics' Profit After Tax plummeted by 62369.03% in 2021 and then soared by 6029.56% in 2022.
- Over the past 5 years, Relay Therapeutics' Profit After Tax (Quarter) stood at -$67.5 million in 2021, then fell by 0.07% to -$67.5 million in 2022, then dropped by 23.69% to -$83.5 million in 2023, then increased by 8.97% to -$76.0 million in 2024, then rose by 2.44% to -$74.1 million in 2025.
- Its last three reported values are -$74.1 million in Q3 2025, -$70.4 million for Q2 2025, and -$77.1 million during Q1 2025.